2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(cyclobutanecarbonyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine
C144H143Cl6N27O9S — CID 158022770
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(cyclobutanecarbonyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine
2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(cyclobutanecarbonyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine (PubChem CID 158022770) has the molecular formula C144H143Cl6N27O9S and a molecular weight of 2640.69 g/mol. Its IUPAC name is 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(cyclobutanecarbonyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine.
Molecular Properties
| Compound Name | 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(cyclobutanecarbonyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine |
|---|---|
| PubChem CID | 158022770 |
| Molecular Formula | C144H143Cl6N27O9S |
| Molecular Weight | 2640.69 g/mol |
| Exact Mass | 2635.94 |
| IUPAC Name | 2-[3-[(4-acetylpiperazin-1-yl)methyl]-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(cyclobutanecarbonyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;2-[2-(4-chlorophenyl)-3-[[4-(2-methoxyacetyl)piperazin-1-yl]methyl]imidazo[1,2-a]pyridin-6-yl]benzonitrile;N-[2-(4-chlorophenyl)-3-(morpholin-4-ylmethyl)imidazo[1,2-a]pyridin-6-yl]methanesulfonamide;4-[[2-(4-chlorophenyl)-6-propan-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine;4-[[2-(4-chlorophenyl)-6-prop-1-en-2-ylimidazo[1,2-a]pyrazin-3-yl]methyl]morpholine |
| SMILES | C=C(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.CC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CC(C)c1cn2c(CN3CCOCC3)c(-c3ccc(Cl)cc3)nc2cn1.COCC(=O)N1CCN(Cc2c(-c3ccc(Cl)cc3)nc3ccc(-c4ccccc4C#N)cn23)CC1.CS(=O)(=O)Nc1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCOCC3)n2c1.N#Cc1ccccc1-c1ccc2nc(-c3ccc(Cl)cc3)c(CN3CCN(C(=O)C4CCC4)CC3)n2c1 |
| InChI | InChI=1S/C30H28ClN5O.C28H26ClN5O2.C27H24ClN5O.C20H23ClN4O.C20H21ClN4O.C19H21ClN4O3S/c31-25-11-8-21(9-12-25)29-27(20-34-14-16-35(17-15-34)30(37)22-5-3-6-22)36-19-24(10-13-28(36)33-29)26-7-2-1-4-23(26)18-32;1-36-19-27(35)33-14-12-32(13-15-33)18-25-28(20-6-9-23(29)10-7-20)31-26-11-8-22(17-34(25)26)24-5-3-2-4-21(24)16-30;1-19(34)32-14-12-31(13-15-32)18-25-27(20-6-9-23(28)10-7-20)30-26-11-8-22(17-33(25)26)24-5-3-2-4-21(24)16-29;2*1-14(2)17-12-25-18(13-24-7-9-26-10-8-24)20(23-19(25)11-22-17)15-3-5-16(21)6-4-15;1-28(25,26)22-16-6-7-18-21-19(14-2-4-15(20)5-3-14)17(24(18)12-16)13-23-8-10-27-11-9-23/h1-2,4,7-13,19,22H,3,5-6,14-17,20H2;2-11,17H,12-15,18-19H2,1H3;2-11,17H,12-15,18H2,1H3;3-6,11-12,14H,7-10,13H2,1-2H3;3-6,11-12H,1,7-10,13H2,2H3;2-7,12,22H,8-11,13H2,1H3 |
| InChIKey | FGGFRTDLNBIJMI-UHFFFAOYSA-N |
| XLogP | 25.76 |
| TPSA | 364.41 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 187 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2640.69 |
| LogP ≤ 5 | 25.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 32 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158022770 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.